Shao-Liang Chen
Overview
Explore the profile of Shao-Liang Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
284
Citations
3709
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Gao X, Lee S, Kan J, Zhang J, Lee S, et al.
Ann Intern Med
. 2025 Feb;
PMID: 39961108
Background: The role of transitioning from short dual antiplatelet therapy (DAPT) to potent P2Y12 inhibitor monotherapy in patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation remains inconclusive....
2.
Gao X, Kan J, Wu H, Chen J, Chen X, Wen S, et al.
Am Heart J
. 2025 Feb;
283:81-88.
PMID: 39914556
Background: Intravascular imaging (IVI)- guided percutaneous coronary intervention (PCI) can improve clinical outcomes compared with angiography guidance in patients with complex lesions or acute coronary syndrome. However, the impact of...
3.
Wang G, Zhang R, Chen S, Wang J, Li Y, Zheng M, et al.
Am Heart J
. 2025 Feb;
PMID: 39909342
Background: Our objective was to compare the efficacy and safety of a drug-eluting stent featuring an abluminal bioabsorbable sirolimus-containing polymer coating (BP-SES) with an everolimus-eluting stent with a durable polymer...
4.
Wang F, Wang S, Gu Y, Luo S, Chen A, Kong C, et al.
Clin Transl Med
. 2025 Jan;
15(1):e70168.
PMID: 39763069
Rationale: Coronary artery plaques often develop in regions subjected to disturbed shear stress (DSS), yet the mechanisms underlying this phenomenon remain poorly understood. Our study aimed to elucidate the unknown...
5.
Gao X, Chen A, Tang H, Kong X, Zhang H, Wang Z, et al.
Arterioscler Thromb Vasc Biol
. 2024 Nov;
44(12):2543-2559.
PMID: 39508106
Background: In-stent restenosis is characterized by a significant reduction in lumen diameter within the stented segment, primarily attributed to excessive proliferation of vascular smooth muscle cells (VSMCs) and neointimal hyperplasia....
6.
Gao X, Tian N, Kan J, Li P, Wang M, Sheiban I, et al.
J Am Coll Cardiol
. 2024 Oct;
85(1):1-15.
PMID: 39480378
Background: Side branch stenting is often required during provisional stenting, leading to suboptimal results. Drug-coated balloons (DCB) for the compromised side branch have emerged as an attractive strategy. However, the...
7.
Gao X, Kan J, Wu Z, Anjun M, Chen X, Chen J, et al.
JACC Cardiovasc Interv
. 2024 Oct;
18(3):283-293.
PMID: 39466211
Background: Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) reduces the risk for clinical events in patients with acute coronary syndromes (ACS), compared with angiographic guidance. However, the benefits of IVUS...
8.
Carvalho P, Gewehr D, Nascimento B, Melo L, Burkhardt G, Rivera A, et al.
JAMA Cardiol
. 2024 Oct;
9(12):1094-1105.
PMID: 39382876
Importance: The optimal duration of dual antiplatelet therapy (DAPT) in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) remains under debate. Objectives: To analyze the efficacy and...
9.
Gao X, Ge Z, Kong X, Zhang J, Chen S
JACC Cardiovasc Interv
. 2024 Sep;
17(18):2194.
PMID: 39322369
No abstract available.
10.
Valgimigli M, Hong S, Gragnano F, Chalkou K, Franzone A, da Costa B, et al.
Lancet
. 2024 Sep;
404(10456):937-948.
PMID: 39226909
Background: Dual antiplatelet therapy (DAPT) for 12 months is the standard of care after coronary stenting in patients with acute coronary syndrome (ACS). The aim of this individual patient-level meta-analysis...